🔗 Share this article

Given that America proceeds with sweeping revisions to its vaccine guidelines, a particular individual appears in a surprising turn: Tracy Beth Høeg, a Danish American physician and epidemiologist who rose to prominence by expressing skepticism about coronavirus vaccines during the pandemic and has zeroed in on potential fatalities after COVID-19 vaccination in her short position at the FDA.

Proposed Changes to Pediatric Immunization Program

Public health authorities planned to unveil radical changes to the childhood immunization program earlier this month, aligning the US with the Danish immunization schedule, it is understood – a substantial departure that would place the US out of step with a large portion of the global community with no evidence for public health gain. The planned update has been postponed until the new year.

Instead of the top vaccines chief, Dr. Høeg is set to present at the meeting. She was recently named acting director of the FDA’s Center for Drug Evaluation and Research (CDER), the fifth person to head the division this year.

Consolidating Power at the Regulatory Body

This interim role might represent a closer partnership between the pharmaceutical and vaccine branches as Høeg and Prasad strengthen their influence at the agency – and it suggests a greater focus upon dismantling previously authorized vaccines at the FDA.

The new acting director has repeatedly called for ending specific pediatric shot schedules in the US to become more in line with Denmark's approach, a country with universal health coverage and a number of inhabitants approximately the size of the state of Wisconsin.

So far statements, she has continued to focus on vaccination policy – traditionally the purview of Dr. Prasad, chief of the FDA’s Center for Biologics Evaluation and Research (CBER) – rather than medication approval.

Concerns Over Qualifications

Høeg has no apparent background in pharmaceutical research, approval processes or leadership, which has been typical for past leaders of the biologics center. She has served at the FDA as a top consultant to the agency head and the vaccine center since spring.

“She appears not to have any of the qualifications” for overseeing the drug-regulation department, said a neurologist and psychiatrist. “She’s never run a scientific study. She lacks experience in running a sizeable institution. She has no expertise in industry regulation.”

Former directors of CBER would “understand laws and regulations and the research of pharmaceutical innovation”, commented Dr. Janet Woodcock. “Clearly, she lacks the sort of resume that former directors who led the center have had.”

CDER has an enormous range of responsibilities at the FDA, the former commissioner emphasized.

“The public just pays attention on the innovative therapies, but the off-patent medication office approves numerous generic drugs. There is also a biosimilars division, over-the-counter program and more, and each of these need to be looked after,” Woodcock said. “The responsibility you don’t keep your eye on, that is the part that I always told people is going to come back to haunt you.”

Furthermore, a significant management component to the job, which manages in excess of 5,000 employees. “It’s a enormous management job, if you do it right,” the former official added.

Agency Reaction and Contentious Programs

Regarding questions about Dr. Høeg's qualifications and whether this assignment represents more teamwork among regulatory chiefs on vaccines, a representative responded that the “questions rely on flawed assumptions”.

“Her experience is consistent with the duties of her job,” the representative stated, noting the period Dr. Høeg spent advising the FDA commissioner on “drug safety and oversight research, including computerized risk analysis and immunization monitoring”.

In her interim role, Høeg inherits the agency head's recently launched expedited review system, a disputed expedited drug-approval program that apparently troubled her former heads. “By what process are these therapies being selected for this expedited pathway? Who makes the choices?” Dr. Howard questioned. “There’s a lot of confidentiality occurring at the agency right now.”

Overall, he stated, “the agency looks to be trending towards less stringent rules of pharmaceuticals, with the exception of vaccines.”

Documented Past Work on Immunizations

Regarding vaccines, Dr. Høeg has a more documented, if problematic, history, Howard observe. She authored a analysis using non-validated crowd-sourced reports to estimate the frequency of myocarditis following Covid immunization. She consulted for the Florida top health official Joseph Ladapo, who reportedly have altered data to indicate Covid vaccines are pose a greater threat than they are.

Included in her “wish list” for the current administration featured changing regulations for recently developed shots and discontinuing “unnecessary” vaccines, she said post-election on a audio program. At the FDA, Høeg has reportedly floated the idea of excluding young men from receiving Covid vaccines.

“She’s an all-around dogmatist who begins with her beliefs and reverse-engineers to accommodate the science in a highly misleading, fraudulent fashion,” Dr. Howard stated.

Taking Control and a “Campaign of Retribution”

Dr. Høeg became part of fellow contrarians, {like|